𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease

✍ Scribed by F Bibbiani; J.D Oh; J.P Petzer; N Castagnoli Jr.; J.-F Chen; M.A Schwarzschild; T.N Chase

Book ID
117101006
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
420 KB
Volume
184
Category
Article
ISSN
0014-4886

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continous intracerebroventricular infusi
Continous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease
✍ Dr. J. G. De Yebenes; S. Fahn; S. Lovelle; V. Jackson-Lewis; P. Jorge; M. A. Men 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

We studied the effect of intracerebroventricular infusion of dopamine and dopamine agonists in rat and primate models of Parkinson's disease as an experimental approach to the treatment of levodopa-induced fluctuations. The infusion of dopamine, lisuride, and pergolide into the ventricle ipsilateral

N-0923, a selective dopamine D2 receptor
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease
✍ Dr. J. D. Belluzzi; E. F. Domino; J. M. May; K. S. Bankiewicz; D. A. McAfee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

## Abstract Certain aminotetralins are known to be potent dopamine D~2~ receptor agonists. N‐0923, [‐]2‐(N‐propyl‐N‐2‐thienylethylamino)‐5‐hydroxytetralin HCl, recognizes the high and low affinity states of the D~2~ receptor in membranes from bovine caudate with a K~low~ of 79 nM. The selectivity r